Novacyt - Novacyt Group: Advancing the science of diagnostics скачать в хорошем качестве

Novacyt - Novacyt Group: Advancing the science of diagnostics

Novacyt Group is a global specialist in clinical diagnostics, focused on the design, manufacture and supply of oncology and infectious disease diagnostics products. As a pioneer in clinical diagnostics, Novacyt has a proven history of responding quickly to changing global health needs, including providing testing solutions for Zika, swine flu, and Ebola viruses. Solidifying this position, Novacyt were among the first to respond to the COVID-19 pandemic in 2020, providing a rapid and reliable CE-IVD marked SARS-CoV-2 test kit. Novacyt offer an increasing portfolio of in-vitro diagnostic tests, utilising molecular and protein detection technologies – supporting healthcare and disease prevention across the globe. Deep strengths in product development, commercialisation, contract design and manufacturing ensure quality products and robust supply. The Group has specialist experience and expertise throughout their business units: Primerdesign, Microgen Bioproducts and Lab21 Healthcare – creating solutions for the diagnostics industry, supplying an extensive range of high-quality assays and reagents worldwide.